glp-1 rheumatoid arthritis study Comparative risk of between glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors in type 2 diabetes Targeting the GLP-1/GLP-1R axis to

Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): A randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial

It is argued that gut dysbiosis, a central feature of IBD, is a fundamental trigger that, through a compromised gut barrier, drives systemic inflammation and, subsequently, neuroinflammation

Fibersol-2 is a digestion-resistant soluble dietary fiber that is well tolerated and designed to reach the large intestine, where it functions as a prebiotic by helping nourish beneficial gut bacteria

Emergency care In a life-threatening medical emergency, every second counts